Current best practices and rationalistic perspectives in causation-based prevention, early detection and multidisciplinary treatment of breast and gastric cancer


Gastric & Breast Cancer e-journal
DOI: 10.2122/gbc.2007.0064

COMMENTARY

 

Title: Outcomes of breast cancer patients with and without BRCA1/2 mutations.
Marc Arbyn
 

Since there is no abstract we provide the first sentence
We would like to comment on the Mollerís et al [1] very intererting report in the Journal Int J Cancer for three reasons: (a) the findings of this study are conflicting with another study published most recently in the NEJM [2] that has been criticed for possible biases and errors [3]. (b) Which results are logically excpected and most convincing to the clinic? Here it is to considered that the management of women with family history for which no data from randomized trials exist is a very controversial topic and (c) To provide an analysis of recent data available on the efficacy and safety of surgical and nonsurgical preventive interventions for women with BRCA1/2 muatations [4].

 

Online ISSN : 1109 - 7647
   Print ISSN : 1109 - 7655

We subscribe to the HONcode principles of the HON Foundation. Click to verify. We subscribe to the HONcode principles. Verify here.
please, read our policy about privacy and confidentiality of information and transparency of sponsorship

last update: 3 February 2004